EMMAUS LIFE SCIENCES INC NEW (EMMA) Financials

EMMA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 47.5 million 83.8 million
2023-06-30 50.3 million 85.3 million
2023-03-31 48.9 million 84.9 million
2022-12-31 48.2 million 82.3 million

EMMA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 58000 24000
2023-06-30 -1.3 million 26000
2023-03-31 -1.3 million 1.2 million
2022-12-31 1.7 million 3000

EMMA Net Income

No data available :(

EMMA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 1.5 million - 2.9 million
2023-06-30 1.4 million - 3.0 million
2023-03-31 1.8 million - 3.1 million
2022-12-31 2.0 million - 3.3 million

EMMA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 138.4 million
2023-06-30 52.9 million
2023-03-31 50.7 million
2022-12-31 49.3 million

EMMA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 414000 2.9 million 1.5 million
2023-06-30 5000 320000 4.1 million 2.5 million
2023-03-31 6000 289000 4.9 million 2.3 million
2022-12-31 8000 529000 3.8 million 2.4 million

EMMA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 5.0 million 214000
2023-06-30 10.8 million 508000
2023-03-31 6.8 million 429000
2022-12-31 5.9 million 645000

EMMA

Price: $0.10

52 week price:
0.05
0.35

Earnings Per Share: -0.08 USD

P/E Ratio: -1.25

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 30500

Market Capitalization: 5.6 million

Links: